2019
DOI: 10.1016/j.clae.2019.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 59 publications
(32 citation statements)
references
References 27 publications
0
26
0
Order By: Relevance
“…However, this strategy usually leads to a rapid release of the drug and an initial burst [39]. Several approaches can be used to improve the release behavior, e.g., incorporation into the polymer matrix of ligands or functional monomers with special affinity for the drug, drug-loaded nanoparticles that release the drug in a controlled manner, molecules which act as diffusion barriers to the drug molecules (e.g., vitamin E) or surfactants that interact with the drugs [40][41][42][43].…”
Section: Introductionmentioning
confidence: 99%
“…However, this strategy usually leads to a rapid release of the drug and an initial burst [39]. Several approaches can be used to improve the release behavior, e.g., incorporation into the polymer matrix of ligands or functional monomers with special affinity for the drug, drug-loaded nanoparticles that release the drug in a controlled manner, molecules which act as diffusion barriers to the drug molecules (e.g., vitamin E) or surfactants that interact with the drugs [40][41][42][43].…”
Section: Introductionmentioning
confidence: 99%
“…Due to their distinct electronic configuration and antifungal properties, novel nanomaterials of lanthanide complexes are pursued for biomedical applications, particularly as drug carriers and/or analyte monitoring (Agarwal et al 2018). When contact lenses containing ophthalmic drug are in contact with eyes, the drug will diffuse and enter the post‐lens tear film, thus extending the residence time of drugs on the eye surface for more than 30 min compared to only 2 min for eye drops and thus improving the drug bioavailability of the cornea (Creech et al 2001; Xu et al 2018; Torres‐Luna et al 2019). Even though the contact lens has some major limitations, such as drug absorption and non‐sustained release, it can often release the ophthalmic drug during the first few hours.…”
Section: Introductionmentioning
confidence: 99%
“…Even though the contact lens has some major limitations, such as drug absorption and non‐sustained release, it can often release the ophthalmic drug during the first few hours. Torres‐Luna et al (2019) reported an extended delivery of the drug, namely improving both the loading capacity and duration of drug release, by incorporating cationic surfactants in vitamin E‐loaded contact lenses. In addition, Yañez et al (2008) demonstrated that semi‐interpenetrating poly(vinylpyrrolidone) (PVP) with poly(hydroxyethyl methacrylate) (pHEMA) can provide a slow release of PVP while keeping the high optical clarity, comfortable and safe contact lenses.…”
Section: Introductionmentioning
confidence: 99%
“…However, a major limitation of contact lenses in drug delivery is that most of the drug absorbed in the contact lens is released within the first few hours which limits the use for extended release [9]. Several methods have been employed to increase the release duration of drugs, including nanoparticle-based contact lenses [10], biomimetic and imprinted contact lenses [11], layer-structured contact lenses [12], and lenses with vitamin E diffusion barriers [3,4,8,9,13,14]. A limited number of these approaches were examined in clinical trials such as the treatment of ocular allergy with ketotifen [15] and the treatment of glaucoma with timolol and dorzolamide [16].…”
Section: Introductionmentioning
confidence: 99%